BCIQ Profiles

Company Profile Report

Management tracks: uniQure, Provention, Anaptys, FDA and more

uniQure N.V. (NASDAQ:QURE) promoted CSO Sander van Deventer to EVP, research and product development and Alex Kuta to EVP, operations from SVP, regulatory affairs. As a result, the gene therapy company

Read the full 317 word article

How to gain access

Continue reading with a
two-week free trial.